CONKO-001: FINAL RESULTS OF THE RANDOMIZED, PROSPECTIVE, MULTICENTER PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY WITH GEMCITABINE VERSUS OBSERVATION IN PATIENTS WITH RESECTED PANCREATIC CANCER (PC)

被引：0
|
作者：
Riess, H.
Neuhaus, P.
Post, S.
Gellert, K.
Ridwelski, K.
Schramm, H.
Zuelke, C.
Fahlke, J.
Langrehr, J.
Oettle, H.
机构：
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：45 / 46
页数：2
相关论文
共 50 条
  • [1] CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC)
    Neuhaus, P.
    Riess, H.
    Post, S.
    Gellert, K.
    Ridwelski, K.
    Schramm, H.
    Zuelke, C.
    Fahlke, J.
    Langrehr, J.
    Oettle, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Adjuvant chemotherapy with Gemcitabine prolongs survival in pancreatic cancer patients - final results of the CONKO-001 study
    Oettle, H.
    Neuhaus, P.
    Hochhaus, A.
    Hartmann, J. -T
    Geller, K.
    Ridwelski, K.
    Niedergethmann, M.
    Zuelke, C.
    Fahlke, J.
    Arning, M.
    Sinn, M.
    Hinke, A.
    Riess, H.
    ONKOLOGIE, 2013, 36 : 123 - 123
  • [3] Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial
    Oettle, Helmut
    Neuhaus, Peter
    Hochhaus, Andreas
    Hartmann, Joerg Thomas
    Gellert, Klaus
    Ridwelski, Karsten
    Niedergethmann, Marco
    Zuelke, Carl
    Fahlke, Joerg
    Arning, Michael B.
    Sinn, Marianne
    Hinke, Axel
    Riess, Hanno
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (14): : 1473 - 1481
  • [4] Adjuvant Chemotherapy with Gemcitabine and Long-Term Outcomes among Patients with Resected Pancreatic Cancer. The CONKO-001 Randomized Trial
    Arrondeau, J.
    Neuzillet, C.
    ONCOLOGIE, 2014, 16 (2-3) : 150 - 151
  • [5] A randomised, prospective, multicenter, phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resected pancreatic cancer.
    Neuhaus, P
    Oettle, H
    Post, S
    Gellert, K
    Ridwelski, K
    Schramm, H
    Zülke, C
    Fahlke, G
    Langrehr, J
    Riess, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 1092S - 1092S
  • [6] SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study
    Sinn, M.
    Sinn, B. V.
    Striefler, J. K.
    Lindner, J. L.
    Stieler, J. M.
    Lohneis, P.
    Bischoff, S.
    Blaeker, H.
    Pelzer, U.
    Bahra, M.
    Dietel, M.
    Doerken, B.
    Oettle, H.
    Riess, H.
    Denkert, C.
    ANNALS OF ONCOLOGY, 2014, 25 (05) : 1025 - 1032
  • [7] Analysis of the CONKO-001 trial: Is the validity of the study sufficient to recommend adjuvant chemotherapy for pancreatic cancer?
    Bauer, Katrin
    Henne-Bruns, Doris
    Manzini, Giulia
    INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2023, 34 (01): : 29 - 40
  • [8] CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
    Sinn, Marianne
    Bahra, Marcus
    Liersch, Torsten
    Gellert, Klaus
    Messmann, Helmut
    Bechstein, Wolf
    Waldschmidt, Dirk
    Jacobasch, Lutz
    Wilhelm, Martin
    Rau, Bettina M.
    Gruetzmann, Robert
    Weinmann, Arndt
    Maschmeyer, Georg
    Pelzer, Uwe
    Stieler, Jens M.
    Striefler, Jana K.
    Ghadimi, Michael
    Bischoff, Sven
    Doerken, Bernd
    Oettle, Helmut
    Riess, Hanno
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (29) : 3330 - +
  • [9] A Randomized Phase II Trial of Adjuvant Chemotherapy With Uracil/Tegafur and Gemcitabine Versus Gemcitabine Alone in Patients With Resected Pancreatic Cancer
    Yoshitomi, Hideyuki
    Togawa, Akira
    Kimura, Fumio
    Ito, Hiroshi
    Shimizu, Hiroaki
    Yoshidome, Hiroyuki
    Otsuka, Masayuki
    Kato, Atsushi
    Nozawa, Satoshi
    Furukawa, Katsunori
    Miyazaki, Masaru
    CANCER, 2008, 113 (09) : 2448 - 2456
  • [10] JASPAC 01: Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for patients with resected pancreatic cancer
    Fukutomi, Akira
    Uesaka, Katsuhiko
    Boku, Narikazu
    Kanemoto, Hideyuki
    Konishi, Masaru
    Matsumoto, Ippei
    Kaneoka, Yuji
    Shimizu, Yasuhiro
    Nakamori, Shoji
    Sakamoto, Hirohiko
    Morinaga, Soichiro
    Kainuma, Osamu
    Imai, Koji
    Sata, Naohiro
    Hishinuma, Shoichi
    Nakamura, Takayuki
    Kanai, Michio
    Hirano, Satoshi
    Yoshikawa, Yukinobu
    Ohashi, Yasuo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345